164 related articles for article (PubMed ID: 9163704)
1. A xanthine oxidase inhibitor 1'-acetoxychavicol acetate inhibits azoxymethane-induced colonic aberrant crypt foci in rats.
Tanaka T; Makita H; Kawamori T; Kawabata K; Mori H; Murakami A; Satoh K; Hara A; Ohigashi H; Koshimizu K
Carcinogenesis; 1997 May; 18(5):1113-8. PubMed ID: 9163704
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate.
Tanaka T; Kawabata K; Kakumoto M; Makita H; Matsunaga K; Mori H; Satoh K; Hara A; Murakami A; Koshimizu K; Ohigashi H
Jpn J Cancer Res; 1997 Sep; 88(9):821-30. PubMed ID: 9369929
[TBL] [Abstract][Full Text] [Related]
3. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H
Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322
[TBL] [Abstract][Full Text] [Related]
4. Suppression of azoxymethane-induced colonic aberrant crypt foci by dietary exposure to a novel synthesized retinoidal butenolide, 5-hydroxy-4-(2-phenyl-(E)ethenyl)-2(5H)-furanone, in rats.
Kawamori T; Tanaka T; Hirose Y; Satoh K; Hara A; Torihara M; Tamai Y; Yamahara J; Mori H
Cancer Lett; 1995 Jun; 92(2):159-65. PubMed ID: 7600526
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive effect of a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate, on rat oral carcinogenesis.
Ohnishi M; Tanaka T; Makita H; Kawamori T; Mori H; Satoh K; Hara A; Murakami A; Ohigashi H; Koshimizu K
Jpn J Cancer Res; 1996 Apr; 87(4):349-56. PubMed ID: 8641965
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis.
Tanaka T; Kojima T; Suzui M; Mori H
Cancer Res; 1993 Sep; 53(17):3908-13. PubMed ID: 8358716
[TBL] [Abstract][Full Text] [Related]
7. Suppression of azoxymethane-induced rat colon aberrant crypt foci by dietary protocatechuic acid.
Kawamori T; Tanaka T; Kojima T; Suzui M; Ohnishi M; Mori H
Jpn J Cancer Res; 1994 Jul; 85(7):686-91. PubMed ID: 8071110
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet.
Tanaka T; Shimizu M; Kohno H; Yoshitani S; Tsukio Y; Murakami A; Safitri R; Takahashi D; Yamamoto K; Koshimizu K; Ohigashi H; Mori H
Life Sci; 2001 Sep; 69(16):1935-45. PubMed ID: 11693274
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of d-limonene on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
Kawamori T; Tanaka T; Hirose Y; Ohnishi M; Mori H
Carcinogenesis; 1996 Feb; 17(2):369-72. PubMed ID: 8625465
[TBL] [Abstract][Full Text] [Related]
10. Citrus auraptene inhibits chemically induced colonic aberrant crypt foci in male F344 rats.
Tanaka T; Kawabata K; Kakumoto M; Makita H; Hara A; Mori H; Satoh K; Hara A; Murakami A; Kuki W; Takahashi Y; Yonei H; Koshimizu K; Ohigashi H
Carcinogenesis; 1997 Nov; 18(11):2155-61. PubMed ID: 9395216
[TBL] [Abstract][Full Text] [Related]
11. Suppressing effects of 6-(2,5-dichlorophenyl)-2,4-diamino-1,3,5-triazine and related synthetic compounds on azoxymethane-induced aberrant crypt foci in rat colon.
Hirose Y; Tanaka T; Makita H; Yang M; Satoh K; Hara A; Maeda M; Toriyama HB; Mori H; Tsuda H
Jpn J Cancer Res; 1996 Jun; 87(6):549-54. PubMed ID: 8766516
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of azoxymethane-induced aberrant crypt foci in rats by natural compounds, caffeine, quercetin and morin.
Tanaka T; Kawabata K; Honjo S; Kohno H; Murakami M; Shimada R; Matsunaga K; Yamada Y; Shimizu M
Oncol Rep; 1999; 6(6):1333-40. PubMed ID: 10523707
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of azoxymethane-induced colon carcinogenesis by dietary feeding of S-methyl methane thiosulfonate in male F344 rats.
Kawamori T; Tanaka T; Ohnishi M; Hirose Y; Nakamura Y; Satoh K; Hara A; Mori H
Cancer Res; 1995 Sep; 55(18):4053-8. PubMed ID: 7664279
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon.
Rao CV; Simi B; Reddy BS
Carcinogenesis; 1993 Nov; 14(11):2219-25. PubMed ID: 8242846
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.
Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS
Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin.
Tanaka T; Makita H; Kawabata K; Mori H; Kakumoto M; Satoh K; Hara A; Sumida T; Tanaka T; Ogawa H
Carcinogenesis; 1997 May; 18(5):957-65. PubMed ID: 9163681
[TBL] [Abstract][Full Text] [Related]
17. Suppression of azoxymethane-induced colonic aberrant crypt foci by a nitric oxide synthase inhibitor.
Kawamori T; Takahashi M; Watanabe K; Ohta T; Nakatsugi S; Sugimura T; Wakabayashi K
Cancer Lett; 2000 Jan; 148(1):33-7. PubMed ID: 10680590
[TBL] [Abstract][Full Text] [Related]
18. Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: the inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes.
Tanaka T; Kawabata K; Kakumoto M; Hara A; Murakami A; Kuki W; Takahashi Y; Yonei H; Maeda M; Ota T; Odashima S; Yamane T; Koshimizu K; Ohigashi H
Cancer Res; 1998 Jun; 58(12):2550-6. PubMed ID: 9635577
[TBL] [Abstract][Full Text] [Related]
19. Catalpa seed oil rich in 9t,11t,13c-conjugated linolenic acid suppresses the development of colonic aberrant crypt foci induced by azoxymethane in rats.
Suzuki R; Yasui Y; Kohno H; Miyamoto S; Hosokawa M; Miyashita K; Tanaka T
Oncol Rep; 2006 Nov; 16(5):989-96. PubMed ID: 17016582
[TBL] [Abstract][Full Text] [Related]
20. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
